These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

566 related items for PubMed ID: 29924357

  • 1. Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment.
    Maurer E, Hörtnagl C, Lackner M, Grässle D, Naschberger V, Moser P, Segal E, Semis M, Lass-Flörl C, Binder U.
    Med Mycol; 2019 Apr 01; 57(3):351-362. PubMed ID: 29924357
    [Abstract] [Full Text] [Related]

  • 2. Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India.
    Chowdhary A, Kathuria S, Singh PK, Sharma B, Dolatabadi S, Hagen F, Meis JF.
    Mycoses; 2014 Dec 01; 57 Suppl 3():97-107. PubMed ID: 25250768
    [Abstract] [Full Text] [Related]

  • 3. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
    Riley TT, Muzny CA, Swiatlo E, Legendre DP.
    Ann Pharmacother; 2016 Sep 01; 50(9):747-57. PubMed ID: 27307416
    [Abstract] [Full Text] [Related]

  • 4. A Revised Species Concept for Opportunistic Mucor Species Reveals Species-Specific Antifungal Susceptibility Profiles.
    Wagner L, de Hoog S, Alastruey-Izquierdo A, Voigt K, Kurzai O, Walther G.
    Antimicrob Agents Chemother; 2019 Aug 01; 63(8):. PubMed ID: 31182532
    [Abstract] [Full Text] [Related]

  • 5. Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis.
    Gebremariam T, Wiederhold NP, Alqarihi A, Uppuluri P, Azie N, Edwards JE, Ibrahim AS.
    J Antimicrob Chemother; 2017 Feb 01; 72(2):462-466. PubMed ID: 27798213
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Alternative ergosterol biosynthetic pathways confer antifungal drug resistance in the human pathogens within the Mucor species complex.
    Navarro-Mendoza MI, Pérez-Arques C, Parker J, Xu Z, Kelly S, Heitman J.
    mBio; 2024 Aug 14; 15(8):e0166124. PubMed ID: 38980037
    [Abstract] [Full Text] [Related]

  • 9. Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales.
    Espinel-Ingroff A, Chakrabarti A, Chowdhary A, Cordoba S, Dannaoui E, Dufresne P, Fothergill A, Ghannoum M, Gonzalez GM, Guarro J, Kidd S, Lass-Flörl C, Meis JF, Pelaez T, Tortorano AM, Turnidge J.
    Antimicrob Agents Chemother; 2015 Mar 14; 59(3):1745-50. PubMed ID: 25583714
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The non-mammalian host Galleria mellonella can be used to study the virulence of the fungal pathogen Candida tropicalis and the efficacy of antifungal drugs during infection by this pathogenic yeast.
    Mesa-Arango AC, Forastiero A, Bernal-Martínez L, Cuenca-Estrella M, Mellado E, Zaragoza O.
    Med Mycol; 2013 Jul 14; 51(5):461-72. PubMed ID: 23170962
    [Abstract] [Full Text] [Related]

  • 14. Galleria mellonella as a host model to study Aspergillus terreus virulence and amphotericin B resistance.
    Maurer E, Browne N, Surlis C, Jukic E, Moser P, Kavanagh K, Lass-Flörl C, Binder U.
    Virulence; 2015 Jul 14; 6(6):591-8. PubMed ID: 26107350
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antifungal combinations in Mucorales: A microbiological perspective.
    Schwarz P, Cornely OA, Dannaoui E.
    Mycoses; 2019 Sep 14; 62(9):746-760. PubMed ID: 30830980
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis.
    Luo G, Gebremariam T, Lee H, French SW, Wiederhold NP, Patterson TF, Filler SG, Ibrahim AS.
    Antimicrob Agents Chemother; 2013 Jul 14; 57(7):3340-7. PubMed ID: 23650163
    [Abstract] [Full Text] [Related]

  • 19. Virulence of Candida haemulonii complex in Galleria mellonella and efficacy of classical antifungal drugs: a comparative study with other clinically relevant non-albicans Candida species.
    Silva LN, Campos-Silva R, Ramos LS, Trentin DS, Macedo AJ, Branquinha MH, Santos ALS.
    FEMS Yeast Res; 2018 Nov 01; 18(7):. PubMed ID: 30052907
    [Abstract] [Full Text] [Related]

  • 20. Experimental murine model of disseminated infection by Saksenaea vasiformis: successful treatment with posaconazole.
    Salas V, Pastor FJ, Calvo E, Sutton D, García-Hermoso D, Mayayo E, Dromer F, Fothergill A, Alvarez E, Guarro J.
    Med Mycol; 2012 Oct 01; 50(7):710-5. PubMed ID: 22458251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.